Anti-ERBB3/ HER3 Antibody (Patritumab deruxtecan)
Catalog No.
F1567
Anti-ERBB3/ HER3 Antibody (Patritumab deruxtecan)
Featured Products
Patritumab deruxtecan (HER3-DXd) is an antibody-active molecule conjugate (ADC) composed of the fully human anti-HER3 IgG1 monoclonal antibody patritumab linked to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker [1].
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.86 kDa
Dry ice
2227102-46-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
U3-1402
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P21860
Human
Dxd
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The drug-to-antibody ratio (DAR) of the Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan) is 8.0.
ERBB3 / HER3
Please avoid freeze-thaw cycles.